Samuel Melville, M.D. (he/him/his)

  • Resident Physician, Obstetrics and Gynecology, School of Medicine

Education and training

  • Degrees

    • M.D., 2023, University of Southern California, Keck School of Medicine

  • Internship

    • Oregon Health and Science University - Obstetrics and Gynecology

  • Residency

    • Obstetrics and Gynecology, Oregon Health and Science University

  • Certifications

    • ACLS, BLS, NRP

Memberships and associations:

  • American College of Obstetrics and Gynecology
  • Alpha Omega Alpha
  • Phi Beta Kappa

Publications

Selected publications

  • Barakzai S, Dahl M, Melville S, Koltun-Baker E, Rangel E, Dancz C. . Rate of unanticipated pathology at the time of hysterectomy for pelvic organ prolapse in an underscreened population.. American Journal of Obstetrics & Gynecology. (2021); 224(6): 782-783. Pub Status: Published.
  • Koltun-Baker E, Barakzai S, Dahl M, Melville S, Dancz C. Perioperative complications after hysterectomy for pelvic organ prolapse at a safety net teaching hospital: an observational cohort study. . American Journal of Obstetrics & Gynecology. (2021); 224(6): 784. Pub Status: Published.
  • Melville S, Barakzai S, Koltun-Baker E, Dahl M, Dancz C. The cost of unindicated preoperative evaluation for hysterectomy for prolapse at a safety-net hospital: an observational descriptive study. . AJOG Global Reports. (2022); 2(3): n/a. Cited in PubMed; PMID: In progress. Pub Status: Published.
  • Melville S, Barakzai S, Koltun-Baker E, Dahl M, Dancz C. The cost of unindicated preoperative evaluation for hysterectomy for prolapse at a safety-net hospital: an observational descriptive study. . American Journal of Obstetrics & Gynecology. (2021); 224(6): 785-786. Pub Status: Published.
  • Rangel E, Barakzai S, Dahl M, Melville S, Koltun-Baker E, Dancz C. Trends in adnexectomy practices at the time of hysterectomy for prolapse at a safety-net hospital.. American Journal of Obstetrics & Gynecology. (2021); 224(6): 796-797. Pub Status: Published.
  • Mandelbaum RS, Melville SJF, Violette CJ, Guner JZ, Doody KA, Matsuzaki S, Quinn MM, Ouzounian JG, Paulson RJ, Matsuo K. The association between uterine adenomyosis and adverse obstetric outcomes: A propensity score-matched analysis. Acta Obstet Gynecol Scand. 2023 Apr 23. doi: 10.1111/aogs.14581. Epub ahead of print. PMID: 37087741.
  • Mandelbaum RS, Melville S, Masjedi A; Raj-Derouin N, Sriprasert I, Quinn M, Guner J, Paulson R, Wilcox J. Clomiphene citrate throughout the duration of ovarian stimulation: an approach to decrease costs, reduce injection burden, and prevent premature ovulation in patients with diminished ovarian reserve. Published, Journal of Assisted Reproduction and Genetics, 2025.
  • Melville SJF, Shi J, Garg B, Caughey AB, Kornfield M. Targeted Regulation ofAbortion Providers Laws and Pregnancies Conceived Through Fertility Treatment.JAMA Health Forum. 2026 Jan 2;7(1):e255920. doi:10.1001/jamahealthforum.2025.5920. PMID: 41511795; PMCID: PMC12789955. 
  • Barakzai S, Koltun-Baker E, Melville SJF, Rangel E, Dahl M, Dancz CE. Ratesof unanticipated premalignant and malignant lesions at the time of hysterectomyperformed for pelvic organ prolapse in an underscreened population. AJOG GlobRep. 2023 May 6;3(2):100217. doi: 10.1016/j.xagr.2023.100217. PMID: 37275440;PMCID: PMC10232886. 
  • Melville SJF, Barakzai S, Dahl M, Koltun-Baker E, Rangel E, Dancz CE.Estimated costs of preoperative evaluation of postmenopausal hysterectomy forprolapse at a safety-net hospital: an observational descriptive study. AJOG GlobRep. 2022 Jul 28;2(3):100078. doi: 10.1016/j.xagr.2022.100078. PMID: 36276784;PMCID: PMC9563550. 
  • Melville SJF, Mandelbaum A, Shi J, Kornfield M, Caughey AB, Krieg SA. Invitro fertilization with preimplantation genetic testing compared with donorsperm and natural conception among male Robertsonian translocation carriers: acost-effectiveness analysis. F S Rep. 2025 Jun 25;6(3):280-288. doi:10.1016/j.xfre.2025.06.005. PMID: 41054710; PMCID: PMC12496424. 
  • Mandelbaum RS, Melville S, Masjedi A, Raj-Derouin N, Sriprasert I, Quinn MM,Paulson RJ, Wilcox JG, Guner JZ. Clomiphene citrate throughout the duration ofovarian stimulation in patients with diminished ovarian reserve: an approach todecrease costs, reduce injection burden, and prevent premature ovulation. JAssist Reprod Genet. 2025 Mar;42(3):791-797. doi: 10.1007/s10815-025-03412-w.Epub 2025 Feb 1. PMID: 39893355; PMCID: PMC11950535. 
  • Mandelbaum RS, Melville SJF, Violette CJ, Guner JZ, Doody KA, Matsuzaki S,Quinn MM, Ouzounian JG, Paulson RJ, Matsuo K. The association between uterineadenomyosis and adverse obstetric outcomes: A propensity score-matched analysis.Acta Obstet Gynecol Scand. 2023 Jul;102(7):833-842. doi: 10.1111/aogs.14581.Epub 2023 Apr 23. PMID: 37087741; PMCID: PMC10333655. 
  • Mandelbaum RS, Agarwal R, Melville S, Violette CJ, Winer S, Shoupe D, MatsuoK, Paulson RJ, Quinn MM. A comparison of letrozole regimens for ovulationinduction in women with polycystic ovary syndrome. F S Rep. 2024 Mar28;5(2):170-175. doi: 10.1016/j.xfre.2024.03.004. PMID: 38983726; PMCID:PMC11228783.

Publications